Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,344 public trials 2,835 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, Not Recruiting

Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant

NCT03924401

Conditions
Anemia, Anemia, Aplastic, Anemia, Hemolytic, +19 more
Locations
  • Children's of Alabama Birmingham, Alabama, United States
  • Nemours/Alfred I. DuPont Hospital for Children Wilmington, Delaware, United States
  • Childrens Healthcare of Atlanta Atlanta, Georgia, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Effect of Venetoclax on Participants Receiving a Covalent Bruton's Tyrosine Kinase Inhibitor (cBTKi) for First-line Chronic Lymphocytic Leukemia (1L CLL) to Achieve Deep Durable Remissions to Allow Off-treatment Period

NCT06524375

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Rocky Mountain Cancer Centers (Aurora) - USOR Aurora, Colorado, United States
  • Cancer Specialists of North Florida Jacksonville, Florida, United States
  • Fort Wayne Medical Oncology and Hematology, Inc Fort Wayne, Indiana, United States
View all 20 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)

NCT04562766

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • University of Southern California_Investigational Site Number 84024 Los Angeles, California, United States
  • UCSF Benioff Children's Hospital San Francisco_Investigational Site Number 84020 San Francisco, California, United States
  • Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center_Investigational Site Number 84037 Torrance, California, United States
  • The Oncology Institute of Hope and Innovation_Investigational Site Number 84031 Whittier, California, United States
View all 155 locations
View Trial Details
Active, Not Recruiting

A Phase 1 Study of BMF-500 in Adults With Acute Leukemia

NCT05918692

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

A Study to Assess the Safety and Efficacy of Two Combinations of Isocitrate Dehydrogenase (IDH) Mutant Targeted Therapies Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) Harboring IDH Mutations Who Are Not Candidates to Receive Intensive Induction Chemotherapy

NCT02677922

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations
  • Local Institution - 105 Duarte, California, United States
  • Local Institution - 107 New Haven, Connecticut, United States
  • Local Institution - 108 Chicago, Illinois, United States
  • Local Institution - 103 Chicago, Illinois, United States
View all 49 locations
View Trial Details

Related conditions